Application 020397

Type
NDA
Sponsor
COVIS PHARMA BV

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ZANAFLEXTIZANIDINE HYDROCHLORIDETABLET;ORALEQ 4MG BASEYesYes
002ZANAFLEXTIZANIDINE HYDROCHLORIDETABLET;ORALEQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N020397-001ZANAFLEXTIZANIDINE HYDROCHLORIDEEQ 4MG BASETABLET / ORALABRLD, RS1996-11-27
N020397-002ZANAFLEXTIZANIDINE HYDROCHLORIDEEQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD2000-02-04

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
N020397-001AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-18 06:07:402026-07N020397-001ZANAFLEXEQ 4MG BASETABLET / ORALABRLD, RS1996-11-27caaa826d4ba7…
2026-08-18 06:07:402026-07N020397-002ZANAFLEXEQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD2000-02-04caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N020397-001ZANAFLEXEQ 4MG BASETABLET / ORALABRLD, RS1996-11-27011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020397-002ZANAFLEXEQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD2000-02-04011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020397-001ZANAFLEXEQ 4MG BASETABLET / ORALABRLD, RS1996-11-2731067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020397-002ZANAFLEXEQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD2000-02-0431067a03dcf5…
2025-08-23 18:47 UTC2025-08N020397-001ZANAFLEXEQ 4MG BASETABLET / ORALABRLD, RS1996-11-276a471c1ec25d…
2025-08-23 18:47 UTC2025-08N020397-002ZANAFLEXEQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD2000-02-046a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020397-001ZANAFLEXEQ 4MG BASETABLET / ORALABRLD, RS1996-11-27fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020397-002ZANAFLEXEQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD2000-02-04fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020397-001ZANAFLEXEQ 4MG BASETABLET / ORALABRLD, RS1996-11-27b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020397-002ZANAFLEXEQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD2000-02-04b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020397-001ZANAFLEXEQ 4MG BASETABLET / ORALABRLD, RS1996-11-2703ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020397-002ZANAFLEXEQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD2000-02-0403ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N020397-001ZANAFLEXEQ 4MG BASETABLET / ORALABRLD, RS1996-11-272680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N020397-002ZANAFLEXEQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD2000-02-042680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N020397-001ZANAFLEXEQ 4MG BASETABLET / ORALABRLD, RS1996-11-275bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N020397-002ZANAFLEXEQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD2000-02-045bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N020397-001ZANAFLEXEQ 4MG BASETABLET / ORALABRLD, RS1996-11-27d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N020397-002ZANAFLEXEQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD2000-02-04d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N020397-001ZANAFLEXEQ 4MG BASETABLET / ORALABRLD, RS1996-11-27d06236e962d9…
2024-10-29 15:01 UTC2024-10N020397-002ZANAFLEXEQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD2000-02-04d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N020397-001ZANAFLEXEQ 4MG BASETABLET / ORALABRLD, RS1996-11-2779d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N020397-002ZANAFLEXEQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD2000-02-0479d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N020397-001ZANAFLEXEQ 4MG BASETABLET / ORALABRLD, RS1996-11-27301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N020397-002ZANAFLEXEQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD2000-02-04301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N020397-001ZANAFLEXEQ 4MG BASETABLET / ORALABRLD, RS1996-11-271e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N020397-002ZANAFLEXEQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD2000-02-041e350fbaab3a…
2024-05-31 18:47 UTC2024-05N020397-001ZANAFLEXEQ 4MG BASETABLET / ORALABRLD, RS1996-11-278072bd15b7f6…
2024-05-31 18:47 UTC2024-05N020397-002ZANAFLEXEQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD2000-02-048072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N020397-001ZANAFLEXEQ 4MG BASETABLET / ORALABRLD, RS1996-11-275c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N020397-002ZANAFLEXEQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD2000-02-045c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N020397-001ZANAFLEXEQ 4MG BASETABLET / ORALABRLD, RS1996-11-275d02ea3f76ae…
2022-04-08 23:34 UTC2022-04N020397-002ZANAFLEXEQ 2MG BASETABLET / ORALRLD2000-02-045d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N020397-001ZANAFLEXEQ 4MG BASETABLET / ORALABRLD, RS1996-11-274b0b4de00fa7…
2022-04-04 05:41 UTC2022-04N020397-002ZANAFLEXEQ 2MG BASETABLET / ORALRLD2000-02-044b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N020397-001ZANAFLEXEQ 4MG BASETABLET / ORALABRLD, RS1996-11-2774a2ff9319b5…
2019-12-13 00:20 UTC2019-12N020397-002ZANAFLEXEQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**TABLET / ORALRLD2000-02-0474a2ff9319b5…
2022-03-09 01:35 UTC2022-03N020397-001ZANAFLEXEQ 4MG BASETABLET / ORALABRLD, RS1996-11-27bb7c543d1eb4…
2022-03-09 01:35 UTC2022-03N020397-002ZANAFLEXEQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD2000-02-04bb7c543d1eb4…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-18 06:07:402026-07N020397-001AB1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N020397-001AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020397-001AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08N020397-001AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020397-001AB1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020397-001AB1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020397-001AB103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N020397-001AB12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N020397-001AB15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N020397-001AB1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N020397-001AB1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N020397-001AB179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N020397-001AB1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N020397-001AB11e350fbaab3a…
2024-05-31 18:47 UTC2024-05N020397-001AB18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N020397-001AB15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N020397-001AB15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N020397-001AB14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N020397-001AB174a2ff9319b5…
2022-03-09 01:35 UTC2022-03N020397-001AB1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N020397-001AB1782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N020397-001AB187673890dc5c…
2021-03-12 10:30 UTC2021-03N020397-001AB15aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N020397-001AB18869cabd3fbd…
2020-11-12 02:37 UTC2020-11N020397-001AB1c0c555d07b60…
2019-12-14 00:12 UTC2019-12N020397-001AB13f01610625f2…
2019-09-15 20:21 UTC2019-09N020397-001AB1b00525d2431f…
2019-07-19 19:46 UTC2019-07N020397-001AB1ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N020397-001AB16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N020397-001AB11c564ffb4f44…
2023-12-20 04:57 UTC2023-12N020397-001AB1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N020397-001AB1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N020397-001AB19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N020397-001AB1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N020397-001AB13f0d92c62455…
2023-05-13 08:27 UTC2023-05N020397-001AB1053a50430f4f…
2023-01-26 05:58 UTC2023-01N020397-001AB13bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N020397-001AB13a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N020397-001AB1f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09N020397-001AB1e64feba35796…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ZanaflexTIZANIDINE HYDROCHLORIDELegacy Pharma USA, Inc.60c27d35-7349-4fc6-86ad-70fffdbe3e082026-01-02Warnings, Adverse reactionsExact identifier
application applno (NDA): 020397
application number: NDA020397
ZanaflexTIZANIDINE HYDROCHLORIDECovis Pharma US, Inc043d9e51-bfa2-4add-9058-5ece332f7e992025-05-05Warnings, Adverse reactionsExact identifier
application applno (NDA): 020397
application number: NDA020397
ndc (product): 70515-594

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 7 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
10144-594Zanaflextizanidine hydrochlorideAcorda Therapeutics, Inc.NDACurrent
55289-612Zanaflextizanidine hydrochloridePD-Rx Pharmaceuticals, Inc.NDACurrent
55289-612Zanaflextizanidine hydrochloridePD-Rx Pharmaceuticals, Inc.NDACurrent
55289-612Zanaflextizanidine hydrochloridePD-Rx Pharmaceuticals, Inc.NDACurrent
70515-594Zanaflextizanidine hydrochlorideCovis Pharma US, IncNDACurrent
70515-594Zanaflextizanidine hydrochlorideCovis PharmaNDACurrent
70515-594Zanaflextizanidine hydrochlorideCovis PharmaNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
80331SUPPL 2025-01-21
80432SUPPL 2024-11-26
78621SUPPL 2024-06-04
78610SUPPL 2024-06-03
24904SUPPL2013-11-08
12535SUPPL2013-11-08
24903SUPPL2013-03-21
41331SUPPL2007-07-09
12534SUPPL2006-08-04
2474SUPPL2006-08-04
24902SUPPL2002-11-27
57447ORIG1997-04-11